Similar articles

• Mycophenolate mofetil therapy for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis.

  Tsuchiya H, Tsuno H, Inoue M, Takahashi Y, Yamashita H, Kaneko H, Kano T, Mimori A. Tsuchiya H, et al. Mod Rheumatol. 2014 Jul;24(4):694-6. doi: 10.3109/14397595.2013.874762. Epub 2014 Feb 7. Mod Rheumatol. 2014. PMID: 24506658 No abstract available.
• Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug.

  Saketkoo LA, Espinoza LR. Saketkoo LA, et al. Arch Intern Med. 2008 Aug 11;168(15):1718-9. doi: 10.1001/archinte.168.15.1718. Arch Intern Med. 2008. PMID: 18695091 No abstract available.
• Interstitial lung disease as a presenting manifestation of microscopic polyangiitis successfully treated with mycophenolate mofetil.

  Gómez-Puerta JA, Espinosa G, Morlà R, Cid MC, Cervera R. Gómez-Puerta JA, et al. Clin Exp Rheumatol. 2009 Jan-Feb;27(1):166-7. Clin Exp Rheumatol. 2009. PMID: 19327249 Review. No abstract available.
• Mycophenolate mofetil for the patients with interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibodies.

  Hayashi M, Kikuchi T, Takada T. Hayashi M, et al. Clin Rheumatol. 2017 Jan;36(1):239-240. doi: 10.1007/s10067-016-3443-2. Epub 2016 Oct 7. Clin Rheumatol. 2017. PMID: 27718019 No abstract available.
• Mycophenolate mofetil as induction therapy after liver transplantation.

  McDiarmid SV. McDiarmid SV. Liver Transpl Surg. 1999 Jul;5(4 Suppl 1):S85-9. doi: 10.1053/JTLS005s00085. Liver Transpl Surg. 1999. PMID: 10431021 Review. No abstract available.